Literature DB >> 18506761

The transcription factor Egr1 regulates the HIF-1alpha gene during hypoxia.

Sabina Sperandio1, Jessyka Fortin, Roman Sasik, Lynda Robitaille, Jacques Corbeil, Ian de Belle.   

Abstract

Using oligonucleotide expression microarrays we have examined the modulation of gene expression in the DU145 prostate cancer cell line. Our findings confirm that the Egr1 transcription factor is rapidly and transiently upregulated by hypoxia. Furthermore, we have demonstrated that HIF-1alpha mRNA is also transiently upregulated, as is its target gene VEGF. To elucidate the mechanism of the transcriptional upregulation of the HIF-1alpha gene, we have shown that Egr1 is able to directly bind to the HIF-1alpha promoter using chromatin immunoprecipitation. We also provide evidence that the binding of Egr1 is necessary for the trans-activation of the HIF-1alpha promoter. These studies highlight the importance for the Egr1 transcription factor in the hypoxic response in cultured prostate cancer cell lines, and indicate that the response of Egr1 is upstream of HIF-1 in these cells. These studies are the first demonstration that the HIF-1alpha transcription factor is targeted directly by Egr1 in hypoxia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18506761     DOI: 10.1002/mc.20454

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  23 in total

1.  HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway.

Authors:  L Qiang; T Wu; H-W Zhang; N Lu; R Hu; Y-J Wang; L Zhao; F-H Chen; X-T Wang; Q-D You; Q-L Guo
Journal:  Cell Death Differ       Date:  2011-08-05       Impact factor: 15.828

2.  Translational and transcriptional responses in human primary hepatocytes under hypoxia.

Authors:  Gaya K Hettiarachchi; Upendra K Katneni; Ryan C Hunt; Jacob M Kames; John C Athey; Haim Bar; Zuben E Sauna; Joseph R McGill; Juan C Ibla; Chava Kimchi-Sarfaty
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-03-28       Impact factor: 4.052

Review 3.  Modulation of hypoxia-inducible factors (HIF) from an integrative pharmacological perspective.

Authors:  Francisco Javier Rodríguez-Jiménez; Victoria Moreno-Manzano
Journal:  Cell Mol Life Sci       Date:  2011-10-08       Impact factor: 9.261

4.  Profilin 1 is essential for retention and metabolism of mouse hematopoietic stem cells in bone marrow.

Authors:  Junke Zheng; Zhigang Lu; Fatih Kocabas; Ralph T Böttcher; Mercedes Costell; Xunlei Kang; Xiaoye Liu; Ralph J Deberardinis; Qianming Wang; Guo-Qiang Chen; Hesham Sadek; Cheng Cheng Zhang
Journal:  Blood       Date:  2014-01-02       Impact factor: 22.113

Review 5.  The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy.

Authors:  Reshef Tal; James H Segars
Journal:  Hum Reprod Update       Date:  2013-09-29       Impact factor: 15.610

6.  Evidence for transcriptional regulation of the glucose-6-phosphate transporter by HIF-1alpha: Targeting G6PT with mumbaistatin analogs in hypoxic mesenchymal stromal cells.

Authors:  Simon Lord-Dufour; Ian B Copland; Louis-Charles Levros; Martin Post; Abhirup Das; Chaitan Khosla; Jacques Galipeau; Eric Rassart; Borhane Annabi
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

Review 7.  Factors interacting with HIF-1alpha mRNA: novel therapeutic targets.

Authors:  Stefanie Galbán; Myriam Gorospe
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 8.  Is EGR1 a potential target for prostate cancer therapy?

Authors:  Delphine Gitenay; Véronique T Baron
Journal:  Future Oncol       Date:  2009-09       Impact factor: 3.404

9.  Pseudomonas aeruginosa Alkyl quinolones repress hypoxia-inducible factor 1 (HIF-1) signaling through HIF-1α degradation.

Authors:  Claire Legendre; F Jerry Reen; Marlies J Mooij; Gerard P McGlacken; Claire Adams; Fergal O'Gara
Journal:  Infect Immun       Date:  2012-09-04       Impact factor: 3.441

10.  A lncRNA coordinates with Ezh2 to inhibit HIF-1α transcription and suppress cancer cell adaption to hypoxia.

Authors:  Xingwen Wang; Yudong Wang; Li Li; Xuting Xue; Hui Xie; Huaxing Shi; Ying Hu
Journal:  Oncogene       Date:  2019-11-29       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.